News

Research Transfer - Record Funding for LMU Spin-offs

3 Feb 2025

In 2024, LMU spin-offs raised around 230.3 million euros in investments.

Startups emerging from Ludwig-Maximilians-Universität München (LMU) have collectively raised an impressive €230.3 million in funding in 2024. This milestone highlights the strength of LMU’s research ecosystem and its ability to drive innovation across various industries, including biotechnology, quantum computing, and AI-driven software solutions.

To promote research commercialization, LMU offers comprehensive support services, ranging from initial startup consultations and funding guidance to business planning and industry networking.

Notable LMU Spin-Offs and their fundings raised in 2024:

  • Tubulis GmbH (€128M) – Developing next-generation antibody-drug conjugates for more effective cancer treatments.
  • Planqc (€50M) – Advancing digital quantum computing with neutral atom technology.
  • Smart Reporting GmbH (€23M) – Enhancing radiology and pathology workflows through digitized documentation.
  • deepc GmbH (€12.6M) – Creating AI-driven imaging diagnostics for radiologists.
  • Eisbach Bio GmbH (€8.9M) – Innovating in the field of precision oncology.
  • Ethris GmbH (€7.8M) – Pioneering RNA-based therapies and vaccines.

These funding achievements demonstrate LMU’s commitment to bridging the gap between academic research and real-world impact.

🔗 Read more on LMU’s official website: Click here